Printer Friendly

ADVANCED INTERVENTIONAL SYSTEMS COMPLETES ACQUISITION OF POLYMICRO TECHNOLOGIES INC.

        ADVANCED INTERVENTIONAL SYSTEMS COMPLETES ACQUISITION
                   OF POLYMICRO TECHNOLOGIES INC.
    IRVINE, Calif., July 15 /PRNewswire/ -- Advanced Interventional Systems (NASDAQ: LAIS) today announced that it has completed the acquisition of Phoenix-based Polymicro Technologies Inc. (PTI), a supplier of high performance tubing, fibers and related products used primarily in the laser angioplasty and gas chromatography and separations markets.  Advanced Interventional Systems uses the fiber optic products manufactured by PTI in its DYMER(R) 200+ excimer laser angioplasty system recently approved by the federal Food and Drug Administration for the treatment of heart disease.
    Richard B. Crosby, LAIS' chief financial officer, said LAIS acquired the stock of PTI for approximately $1.8 million in cash and 400,000 shares of LAIS stock.
    PTI has a history of profitability with revenues of approximately $6.8 million in its fiscal year ended July 31, 1991 and net income after taxes of $240,000.
    Crosby said, "As a result of the historical profitability of PTI, the acquisition will be non-dilutive to existing LAIS shareholders. We expect PTI to continue to be operated in a profitable fashion while reducing the cost of fiber optics used in the production of LAIS fiber optic catheters as LAIS' volume of catheter products increases.  In fiscal year ended July 31, 1991, LAIS represented 14 percent of Polymicro's revenues."
    According to Crosby, in addition to producing medical fiber used in angioplasty, PTI is also one of the few remaining independent companies providing tubing to the gas chromatography market. Following the acquisition, PTI will operate as an independent subsidiary of LAIS and will continue to provide products to the gas chromatography and separations markets.  Two of PTI's founders will remain with the company, Eugene Maule as president and Gary Nelson as technical vice president.
    "PTI has a long history of innovation with its chromatography and separations customers and will remain committed to the ongoing supply of its customers with innovative products to help grow these markets," Crosby said.
    According to Crosby, the merger will provide both companies the opportunity to improve manufacturing efficiencies and to combine their technical expertise to develop future products for gas chromatography and separation as well as new products for LAIS' excimer laser angioplasty catheters.
    Advanced Interventional Systems pioneered excimer laser angioplasty and is the technological leader in the development of laser systems for cardiovascular applications.  The company was founded in 1986.  In November 1991, Advanced Interventional Systems completed its initial public offering and on Jan. 31, 1992, it received the first and only approval to date from the FDA to market the first laser system designed to treat heart disease.
    -0-                     7/15/92
    /CONTACT:  Richard B. Crosby, CFO of Advanced Interventional Systems, 714-586-1342/
    (LAIS) CO:  Advanced Interventional Systems; Polymicro Technologies Inc. ST:  California, Arizona IN:  MTC SU:  TNM KJ-CH -- LA018 -- 9567 07/15/92 12:55 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 15, 1992
Words:469
Previous Article:LTV BANKRUPTCY JUDGE ORDERS THIRD DAY OF TALKS
Next Article:DETROIT AFSCME WORKERS REJECT PROPOSED CONCESSIONS
Topics:


Related Articles
ADVANCED INTERVENTIONAL SYSTEMS RECEIVES FDA PRE-MARKET APPROVAL
ADVANCED INTERVENTIONAL SYSTEMS REPORTS FISCAL 1991 RESULTS; FINANCIAL PERFORMANCE CONSISTENT WITH RECENT ANALYST PROJECTIONS
ADVANCED INTERVENTIONAL SYSTEMS SIGNS LETTER OF INTENT TO ACQUIRE SUPPLIER OF FIBER OPTICS
LAIS ANNOUNCES PLANS TO REPURCHASE STOCK
ADVANCED INTERVENTIONAL SYSTEMS ANNOUNCES TERMINATION OF MERGER AGREEMENT AND RESTRUCTURING
ROBERT E. WALL RETIRES AS CHAIRMAN & CHIEF EXECUTIVE OFFICER OF ADVANCED INTERVENTIONAL SYSTEMS INC.
Spectranetics Considers Alternatives for Industrial Subsidiary.
Spectranetics Appoints Acting Chief Financial Officer.
Spectranetics to Sell Industrial Subsidiary for $15 Million; Spectranetics to Focus Resources on Core Medical Business.
Spectranetics Core Medical Revenues Increase to a Record $6.6 Million.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters